The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes

Leukemia Research

Volumn 30, Issue 6, 2006, Pages 665-676

  Talby, Leila ^a   Chambost, Hervé ^b   Roubaud, Marie Christine ^c   N'Guyen, Catherine ^d   Milili, Michèle ^a   Loriod, Béatrice ^d   Fossat, Chantal ^b   Picard, Christophe ^e   Gabert, Jean ^e   Chiappetta, Pierre ^f   Michel, Gérard ^b   Schiff, Claudine ^a  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b TIMONE HOSPITAL   (France)

^c Aix Marseille University   (France)

^d Aix Marseille university   (France)

^e HÔPITAL NORD   (France)

^f CENTRE DE PHYSIQUE THÉORIQUE   (France)

Author keywords

Acute lymphoblastic leukemia; Chemosensitivity to therapy; Gene expression profiles; Microarray

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; B LYMPHOBLAST; BCR GENE; CANCER CHEMOTHERAPY; CANCER GENETICS; CD34 SELECTION; CHEMOSENSITIVITY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; INFANT; LEUKEMIA CELL; MICROARRAY ANALYSIS; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPI B GENE;

EID: 33645295228     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.10.007     Document Type: Article

References (42)

1. C.H. Pui, D. Campana, and W.E. Evans Childhood acute lymphoblastic leukaemia-current status and future perspectives Lancet Oncol 2 2001 597 607
2. G. Schaison, M.F. Auclerc, A. Baruchel, T. Leblanc, and G. Leverger Prognosis of acute lymphoblastic leukemia in children Results of the French protocol FRALLE 93 Bull Acad Natl Med 185 2001 149 166 [discussion 160-162]
3. M. Schrappe, A. Reiter, M. Zimmermann, J. Harbott, W.D. Ludwig, and G. Henze Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster Leukemia 14 2000 2205 2222
4. J. Donadieu, M.F. Auclerc, A. Baruchel, T. Leblanc, J. Landman-Parker, and Y. Perel Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study group Br J Haematol 102 1998 729 739
5. J.T. Sandlund, P.L. Harrison, G. Rivera, F.G. Behm, D. Head, and J. Boyett Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia Blood 100 2002 43 47
6. T. Hongo, S. Yajima, M. Sakurai, Y. Horikoshi, and R. Hanada In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia Blood 89 1997 2959 2965
7. R. Pieters, D.R. Huismans, A.H. Loonen, K. Hahlen, A. van der Does-van den Berg, and E.R. van Wering Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia Lancet 338 1991 399 403
8. P.S. Gaynon, A.A. Desai, B.C. Bostrom, R.J. Hutchinson, B.J. Lange, and J.B. Nachman Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review Cancer 80 1997 1717 1726
9. J.J. van Dongen, T. Seriu, E.R. Panzer-Grumayer, A. Biondi, M.J. Pongers-Willemse, and L. Corral Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood Lancet 352 1998 1731 1738
10. H. Cave, J. van derWerff ten Bosch, S. Suciu, C. Guidal, C. Waterkeyn, J. Often European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group Clinical significance of minimal residual disease in childhood acute lymphoblastic leukaemia N Engl J Med 339 1998 591 598
11. T.R. Golub, D.K. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, and J.P. Mesirov Molecular classifbation of cancer class discovery and class prediction by gene expressbn monitoring Science 286 1999 531 537
12. E.J. Yeoh, M.E. Ross, S.A. Shurtleff, W.K. Williams, D. Patel, and R. Mahfouz Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling Cancer Cell 1 2002 133 143
13. M.E. Ross, X. Zhou, G. Song, S.A. Shurtleff, K. Girtman, and W.K. Williams Classification of pediatric acute lymphoblastic leukemia by gene expression profiling Blood 102 2003 2951 2959
14. T. Rozovskaia, O. Ravid-Amir, S. Tillib, G. Getz, E. Feinstein, and H. Agrawal Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements Proc Natl Acad Sci USA 100 2003 7853 7858
15. S. Tsutsumi, T. Taketani, K. Nishimura, X. Ge, T. Taki, and K. Sugita Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements Cancer Res 63 2003 4882 4887
16. A. Kohlmann, C. Schoch, S. Schnittger, M. Dugas, W. Hiddemann, and W. Kern Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients Leukemia 18 2004 63 71
17. F. Bertucci, K. Bernard, B. Loriod, Y.C. Chang, S. Granjeaud, and D. Birnbaum Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples Hum Mol Genet 8 1999 1715 1722
18. Yang YH. Normalization for cDNA Microarray Data. SPIE BiOS, 2001.
19. R. lhaka A language fordata analysis and graphics J Comput Graph Stat 5 1996 299 314
20. E. Beillard, N. Pallisgaard, V.H. van der Velden, W. Bi, R. Dee, and E. van der Schoot Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program Leukemia 17 2003 2474 2486
21. M.B. Eisen, P.T. Spellman, P.O. Brown, and D. Botstein Cluster analysis and display of genome-wide expression patterns Proc Natl Acad Sci USA 95 1998 14863 14868
22. Dudoit. Multiple hypothesis testing in microarray experiments. Statistical Science 2003;18:73-103.
23. A. Holleman, M.H. Cheok, M.L. den Boer, W. Yang, A.J. Veerman, and K.M. Kazemier Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment N Engl J Med 351 2004 533 542
24. J.M. Norgaard, and P. Hokland Biology of multiple drug resistance in acute leukemia Int J Hematol 72 2000 290 297
25. F.J. Staal, M. van der Burg, L.F. Wessels, B.H. Barendregt, M.R. Baert, and C.M. van den Burg DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers Leukemia 17 2003 1324 1332
26. S. Chiaretti, X. Li, R. Gentleman, A. Vitale, M. Vignetti, and F. Mandelli Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival Blood 103 2004 2771 2778
27. G. Cario, M. Stanulla, B.M. Fine, O. Teuffel, N.V. Neuhoff, and A. Schrauder Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia Blood 105 2005 821 826
28. D.S. Krause, M.J. Fackler, C.I. Civin, and W.S. May CD34: structure, biology, and clinical utility Blood 87 1996 1 13
29. F. Lanza, L. Healy, and D.R. Sutherland Structural and functional features of the CD34 antigen: an update J Biol Regul Homeost Agents 15 2001 1 13
30. O. Majdic, J. Stockl, W.F. Pickl, J. Bohuslav, H. Strobl, and C. Scheinecker Signaling and induction of enhanced cytoadhesiveness via the hematopoietic progenitor cell surface molecule CD34 Blood 83 1994 1226 1234
31. A. Manabe, K.G. Murti, E. Coustan-Smith, M. Kumagai, F.G. Behm, and S.C. Raimondi Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells Blood 83 1994 758 766
32. G. Basso, F. Lanza, A. Orfao, S. Moretti, and G. Castoldi Clinical and biological significance of CD34 expression in acute leukemia J Biol Regul Homeost Agents 15 2001 68 78
33. C.H. Pui, M.L. Hancock, D.R. Head, G.K. Rivera, A.T. Look, and J.T. Sandlund Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia Blood 82 1993 889 894
34. N. Cascavilla, P. Musto, G. D'Arena, S. Ladogana, R. Matera, and M. Carotenuto Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression Haematologica 82 1997 31 37
35. C. Tonnelle, M.C. Imbert, D. Sainty, S. Granjeaud, C. N'Guyen, and C. Chabannon Overexpression of dominant-negative Ikaros 6 protein is restricted to a subset of B common adult acute lymphoblastic leukemias that express high levels of the CD34 antigen Hematol J 4 2003 104 109
36. M.J. Borowitz, J. Rubnitz, M. Nash, D.J. Pullen, and B. Camitta Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study Leukemia 12 1998 1764 1770
37. M.D. Tabemero, A.M. Bortoluci, I. Alaejos, M.C. Lopez-Berges, A. Rasillo, and R. Garcia-Sanz Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expresssion Leukemia 15 2001 406 414
38. S. Rao, A. Matsumura, J. Yoon, and M.C. Simon SPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.1 J Biol Chem 274 1999 11115 11124
39. T. Niini, K. Vettenranta, J. Hollmen, M.L. Larramendy, Y. Aalto, and H. Wikman Expression of myeloid-specific genes in childhood acute lymphoblastic leukemia-a cDNA array study Leukemia 16 2002 2213 2221
40. G. Radziwill, R.A. Erdmann, U. Margelisch, and K. Moelling The Bcr kinase downregulates Ras signaling by phosphorylating AF-6 and binding to its PDZ domain Mol Cell Biol 23 2003 4663 4672
41. M. Wetzler, M. Talpaz, G. Yee, S.A. Stass, R.A. Van Etten, and M. Andreeff Cell cycle-related shifts in subcellular localization of BCR: association with mitotic chromosomes and with heterochromatin Proc Natl Acad Sci USA 92 1995 3488 3492
42. E. Laurent, M. Talpaz, M. Wetzler, and R. Kurzrock Cytoplasmic and nuclear localization of the 130 and 160 kDa Bcr proteins Leukemia 14 2000 1892 1897